Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Authors :: Al‐Batran, Salah‐Eddin
Hofheinz, Ralf‐Dieter
Reichart, Alexander
Pauligk, Claudia
Schönherr, Caroline
Schlag, Rudolf
Siegler, Gabriele
Dörfel, Steffen
Koenigsmann, Michael
Zahn, Mark‐Oliver
Schubert, Jörg
Aldaoud, Ali
Höffkes, Heinz‐Gert
Schulz, Holger
Hahn, Lars
Uhlig, Jens
Blau, Wolfgang
Stauch, Martina
Weniger, Jörg
Wolf, Martin
Jacobasch, Lutz
Bildat, Stephan
Wehmeyer, Jürgen
Homann, Nils
Trojan, Jörg
Waidmann, Oliver
Fietz, Thomas
Feustel, Hans‐Peter
Groschek, Matthias
Wierecky, Jan
Waibel, Karin
Mahlmann, Stefan
Schwindel, Uwe
Peters, Uwe
Schuch, Gunter
Pink, Daniel
Eschenburg, Henning
Wörns, Marcus‐A.
Harich, Hans‐Detlev
Weikersthal, Ludwig Fischer
Däßler, Klaus‐Ulrich
Behringer, Dirk M.
Messmann, Helmut
Kretzschmar, Albrecht
Gallmeier, Eike
Forstbauer, Helmut
Kunzmann, Volker
Papke, Jens
Büchner‐Steudel, Petra
Vehling‐Kaiser, Ursula
Springfeld, Christoph
Vogel, Arndt
Ettrich, Thomas J.
Schaaf, Marina
Hausen, Gerrit zur
Götze, Thorsten Oliver
Publication Year :: 2021

Tools